115 related articles for article (PubMed ID: 10224160)
1. VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor.
Nilsson L; Gåfvels M; Musakka L; Ensler K; Strickland DK; Angelin B; Hamsten A; Eriksson P
J Lipid Res; 1999 May; 40(5):913-9. PubMed ID: 10224160
[TBL] [Abstract][Full Text] [Related]
2. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex.
Heegaard CW; Simonsen AC; Oka K; Kjøller L; Christensen A; Madsen B; Ellgaard L; Chan L; Andreasen PA
J Biol Chem; 1995 Sep; 270(35):20855-61. PubMed ID: 7657671
[TBL] [Abstract][Full Text] [Related]
3. Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells.
Nilsson L; Banfi C; Diczfalusy U; Tremoli E; Hamsten A; Eriksson P
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1679-85. PubMed ID: 9812904
[TBL] [Abstract][Full Text] [Related]
4. In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element.
Dichtl W; Ares MP; Stollenwerk M; Giachelli CM; Scatena M; Hamsten A; Eriksson P; Nilsson J
Thromb Haemost; 2000 Oct; 84(4):706-11. PubMed ID: 11057874
[TBL] [Abstract][Full Text] [Related]
5. Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells.
Allison BA; Nilsson L; Karpe F; Hamsten A; Eriksson P
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1354-60. PubMed ID: 10323790
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.
Ren S; Lee H; Hu L; Lu L; Shen GX
J Clin Endocrinol Metab; 2002 Jan; 87(1):286-91. PubMed ID: 11788661
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL.
Sironi L; Mussoni L; Prati L; Baldassarre D; Camera M; Banfi C; Tremoli E
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):89-96. PubMed ID: 8548432
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of plasminogen activator inhibitor-1 in vascular endothelial cells induced by oxidized very low density lipoproteins.
Zhao R; Ma X; Shen GX
Mol Cell Biochem; 2008 Oct; 317(1-2):197-204. PubMed ID: 18597060
[TBL] [Abstract][Full Text] [Related]
9. Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells.
Li XN; Grenett HE; Benza RL; Demissie S; Brown SL; Tabengwa EM; Gianturco SH; Bradley WA; Fless GM; Booyse FM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3215-23. PubMed ID: 9409314
[TBL] [Abstract][Full Text] [Related]
10. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.
Stiko-Rahm A; Wiman B; Hamsten A; Nilsson J
Arteriosclerosis; 1990; 10(6):1067-73. PubMed ID: 2244856
[TBL] [Abstract][Full Text] [Related]
11. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia.
Eriksson P; Nilsson L; Karpe F; Hamsten A
Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):20-6. PubMed ID: 9445251
[TBL] [Abstract][Full Text] [Related]
12. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor.
Battey FD; Gåfvels ME; FitzGerald DJ; Argraves WS; Chappell DA; Strauss JF; Strickland DK
J Biol Chem; 1994 Sep; 269(37):23268-73. PubMed ID: 8083232
[TBL] [Abstract][Full Text] [Related]
13. Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells.
Grenett HE; Benza RL; Fless GM; Li XN; Davis GC; Booyse FM
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1803-9. PubMed ID: 9812921
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
15. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells.
Song CY; Kim BC; Hong HK; Lee HS
Kidney Int; 2005 May; 67(5):1743-52. PubMed ID: 15840021
[TBL] [Abstract][Full Text] [Related]
16. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
[TBL] [Abstract][Full Text] [Related]
17. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
Kaneko T; Wada H; Wakita Y; Minamikawa K; Nakase T; Mori Y; Deguchi K; Shirakawa S
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):385-92. PubMed ID: 8075310
[TBL] [Abstract][Full Text] [Related]
18. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.
Argraves KM; Battey FD; MacCalman CD; McCrae KR; Gåfvels M; Kozarsky KF; Chappell DA; Strauss JF; Strickland DK
J Biol Chem; 1995 Nov; 270(44):26550-7. PubMed ID: 7592875
[TBL] [Abstract][Full Text] [Related]
19. Hypertriglyceridemic VLDL downregulates tissue plasminogen activator gene transcription through cis-repressive region(s) in the tissue plasminogen activator promoter in cultured human endothelial cells.
Tabengwa EM; Benza RL; Grenett HE; Booyse FM
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1675-81. PubMed ID: 10845888
[TBL] [Abstract][Full Text] [Related]
20. Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha -induced PAI-1 expression.
Gruber F; Hufnagl P; Hofer-Warbinek R; Schmid JA; Breuss JM; Huber-Beckmann R; Lucerna M; Papac N; Harant H; Lindley I; de Martin R; Binder BR
Blood; 2003 Apr; 101(8):3042-8. PubMed ID: 12506026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
